$8 Billion Risperdal Punitive Damages Award
October 17, 2019
A Philadelphia jury awarded a Maryland man $1.75 million in compensatory damages (which was later reduced to $680,000) against Johnson & Johnson’s subsidiary unit, Janssen Pharmaceuticals Inc. (“Janssen”), in 2015 but the jury was not permitted at that time to consider awardin[...]
Continue Reading
$70M Risperdal Verdict
July 25, 2016
On July 1, 2016, a Philadelphia jury returned its verdict in the amount of $70 million against Janssen Pharmaceuticals, Inc., which manufactures the antipsychotic medication Risperdal. The Philadelphia verdict is the largest verdict so far in the mass tort litigation involving Risperdal claims that [...]
Continue Reading
